Description générale
INN
Medroxyprogesterone
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 1984
(TRS
722)
pour
Contact with health services for reasons associated with reproduction
Ajouté en 1993
(TRS
850)
pour
Excessive menstruation with irregular cycle
Wikipédia
DrugBank
Recommandations
Section
Injectable hormonal contraceptives
- Parenteral > General injections > IM: 150 mg per mL in 1 mL vial
- Parenteral > General injections > SC: 104 mg per 0.65 mL in pre-filled syringe; 104 mg per 0.65 mL in single dose injection delivery system
Section
Progestogens
- Oral > Solid: 5 mg
Indications